COMMUNIQUÉS West-GlobeNewswire

AIM ImmunoTech Reports Second Quarter 2025 Financial Results and Provides Corporate Update
15/08/2025
Continued progress across pipeline programs with focus on pancreatic cancer Mid-year report of Ampligen ® (rintatolimod) in combination with AstraZeneca’s Imfinzi ® (durvalumab) for the treatment of pancreatic cancer [...]
HeartSciences Announces Conference Participation and Investor Webinar
15/08/2025
Virtual Events Include Investor Webinar and Presentation at Emerging Growth Conference 85 Southlake, TX, Aug. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company") , an [...]
BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor
15/08/2025
First-in-human study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of BGE-102, an orally available small molecule with potential best-in-class profile Initial development planned in obesity; [...]
La Croix-Rouge met sur pied un fonds de secours en réponse aux feux de forêt à Terre-Neuve
15/08/2025
OTTAWA, Ontario, 15 août 2025 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne lance un appel aux dons au profit du Fonds de secours : Feux de forêt de 2025 à Terre-Neuve-et-Labrador afin de venir en aide aux personnes et [...]
Appeal launched to support people impacted by Newfoundland fires
15/08/2025
OTTAWA, Ontario, Aug. 15, 2025 (GLOBE NEWSWIRE) -- The Canadian Red Cross has launched the 2025 Newfoundland & Labrador Wildfires Appeal to help people and communities impacted by fires in the province. Donations to [...]
Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
15/08/2025
Patient enrollment for our ongoing Phase-3 clinical trial of SGT-610 for Gorlin Syndrome has been completed; top-line results are expected in the fourth quarter of 2026 Phase-1b proof-of-concept clinical trial of SGT- [...]
Plus Therapeutics Reports Stockholders’ Equity in Excess of $2.5 million in Compliance with Nasdaq Equity Requirements
15/08/2025
HOUSTON, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform [...]
Catheter Precision, Inc. Announces Effectiveness of 1-for-19 Reverse Stock Split
15/08/2025
FORT MILLS, S.C., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a US based medical device company focused on developing technologically advanced products for the cardiac [...]
Stryker to host investor day
15/08/2025
Portage, Michigan, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host an Investor Day on Thursday, November 13, 2025, at 2:30 p.m. Eastern Time, in Mahwah, New Jersey. A live audio webcast [...]
Vistin Pharma ASA: Second quarter and YTD 2025 financial results
15/08/2025
Oslo, Norway, 15 th of August 2025 Vistin Pharma ASA (VISTN) today announces the financial results for the second quarter of 2025. Revenue in the second quarter ended at MNOK 118 compared to MNOK 106 in Q2 2024. The [...]
Aino Health AB (publ): interim report january-june 2025
15/08/2025
This document in English is a translation of the original in Swedish. In case of any discrepancy, the Swedish original will prevail. Increased turnover. Positive EBITDA. January - June 2025 Turnover totalled 14 848 (12 [...]
EAACI Launches Global Antibiotic Allergy Awareness Campaign at EAACI Congress 2025
15/08/2025
ZURICH, Aug. 15, 2025 (GLOBE NEWSWIRE) -- EAACI has launched its Antibiotic Allergy Awareness Campaign during its 2025 Congress in Glasgow. The initiative begins a global effort to address mislabelling and its link to [...]
L’EAACI lance une campagne mondiale de sensibilisation aux allergies aux antibiotiques lors du EAACI Congress 2025
15/08/2025
ZURICH, 15 août 2025 (GLOBE NEWSWIRE) -- L’EAACI a lancé sa Antibiotic Allergy Awareness Campaign (Campagne de sensibilisation aux allergies aux antibiotiques) à l’occasion de son Congrès 2025 à Glasgow. Cette [...]
Propanc Biopharma Announces Nasdaq Uplisting and Pricing of $4 Million Public Offering
15/08/2025
Propanc common stock expected to begin trading on Nasdaq under the symbol PPCB MELBOURNE, Australia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a [...]
Santhera extends Highbridge convertible bond to 30th September 2025
15/08/2025
Ad hoc announcement pursuant to Art. 53 LRA Pratteln, Switzerland , 15 August , 2025 – Santhera Pharmaceuticals (SIX: SANN) announces that by mutual agreement the Company and Highbridge Capital Management, LLC ( [...]
BioPorto Interim Result for the Second Quarter of 2025 - Continued progress with full execution of strategic objectives and strong NGAL sales growth.
15/08/2025
August 15, 2025 Announcement no. 19 BioPorto Interim Result for the Second Quarter of 2025 - Continued progress with full execution of strategic objectives and strong NGAL sales growth. Copenhagen, Denmark, August 15, [...]
24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with First Phase 1B/2 Trial Readout Expected in 2H 2025
15/08/2025
Breakthrough Protein Phosphatase 2A inhibitor LB-100 Targets Ovarian Clear Cell Carcinoma, Advanced Soft Tissue Sarcoma, and MSS Metastatic Colon Cancer 24/7 Market News Issues Corrected Information on Previously issued [...]
BioStem Technologies Appoints Brandon Poe as Chief Financial Officer
14/08/2025
Seasoned healthcare CFO with senior experience in capital markets and financial operations across private and publicly traded companies to lead BioStem’s financial team POMPANO BEACH, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE [...]
Vaxart to Host Virtual Stockholder Fireside Chat on Wednesday, August 20 to Discuss Reverse Stock Split Proposal
14/08/2025
- ISS and Glass Lewis, leading independent proxy advisory firms, support reverse stock split proposal - - Webcast to begin at 4:30 p.m. ET / 1:30 p.m. PT - SOUTH SAN FRANCISCO, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- [...]

Pages